1274303

Takeda Pharamaceutical Company Limited — FEI 3011999558

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 6, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Longmont, CO (United States)

Citations

IDCFRDescription
442521 CFR 606.60(a)Equipment observed, standardized, calibrated